Today's Stock News: Latest Updates on Public Companies

AI, data centers and compute plays

Cipher Digital (CIFR) began development of lateral pipelines to enable data center expansion with a bring‑your‑own‑generation model, aiming to lower build costs and speed colocations for AI workloads. Infrastructure that bundles power routing with capacity planning is becoming a competitive lever as demand for AI compute grows.

BUUU Group Limited (BUUU) signed a definitive agreement to acquire a majority stake in Brightray Science Inc. and raised over US$60 million in private placements to make industrialized AI data‑center delivery its core growth business. That combination of M&A and capital raises signals rapid scaling in physical AI infrastructure, which could pressure incumbents and reshape regional supply chains.

Bit Origin / SANGRIX (BTOG) rebranded to SANGRIX, framing a strategic pivot toward cloud compute and hardware services; investors will watch capex plans and customer pipeline updates for signs the repositioning moves from narrative to revenue.

Technology, telecom and platform moves

Silicon Motion (SIMO) reached an initial milestone in its EU Cyber Resilience Act compliance program, easing execution risk for embedded and SSD controllers in Europe and supporting market access for device makers.

Quantum X Labs (QXL) announced progress on efficient geometric encoding of complex nuclear environments, a technical advance that could shorten R&D timelines for high‑value simulation workloads and attract commercial partners or IP licensing opportunities.

Telos Corporation (TLS) expanded cyber risk management support for the Office of Naval Intelligence, a contract extension that strengthens Telos's position in federal cyber services and may deepen pipeline visibility across defense customers.

Geospatial, defense and imagery

Planet (PL) signed a seven‑figure agreement with a European defense and intelligence customer, highlighting how recurring defense contracts can boost revenue predictability for high‑cadence imagery providers.

Satellogic (SATL) named SynMax its exclusive maritime intelligence channel for Merlin constellation data, expanding distribution of daily imagery into commercial maritime analytics and reinforcing monetization of persistent observation products.

American Resources Corporation (AREC) joined the Critical Minerals Institute as its first platinum member, a strategic move tying the company to policy and supply‑chain efforts around minerals critical to defense and clean‑energy builds.

AI partnerships, geospatial and robotics

Rail Vision (RVSN) was selected for a U.S. rail industry testing program to evaluate its AI‑powered detection systems in real conditions. Field trials mark an important step from prototype to recurring, contract‑based revenue if performance and integration prove reliable.

Healthcare, biotech and diagnostics

Aptevo (APVO) reported a 93% clinical benefit rate for its mipletamig triplet in frontline TP53‑mutated AML. For a small‑cap oncology player, early efficacy can materially affect valuation if safety and durability are confirmed in larger cohorts.

Co‑Diagnostics (CODX) launched an integrated cloud and mobile infrastructure in India to support diagnostics workflows, strengthening recurring service potential in a large market.

Milestone Pharmaceuticals (MIST) announced NMPA approval of etripamil nasal spray for PSVT in China — the first regulatory approval of etripamil outside the U.S. This approval opens a sizeable market and could meaningfully shift Milestone's growth outlook and revenue projections if launch execution succeeds.

Nexalin Technology (NXL) released a secondary analysis showing previously unreported cognitive improvements in Alzheimer’s patients and plans a U.S. pilot. Repurposed analyses can influence trial design and investor expectations ahead of new studies.

Earnings and corporate results

The Toro Company (TTC) reported record third‑quarter results, underscoring resilient demand for outdoor equipment and margin leverage that can lift related industrial peers.

Baird Medical (BDMD) posted 25% revenue growth and positive net income for the six months ended June 30, 2026, a sign that profitability is emerging for select medical‑equipment small caps.

Debt, buybacks and capital structure

Emergent BioSolutions (EBS) completed repurchase of $75 million of senior unsecured notes, cutting future interest exposure and maturity risk.

Cyabra (CYAB) stockholders approved the conversion and exchange of all outstanding preferred stock, simplifying capital structure and clearing a path for broader equity participation in upside.

SuperX (SUPX) continued share repurchases and reported substantial APAC orders, a combination that signals management confidence and tangible demand validation across the region.

Corporate governance, listings and regulatory moves

DeFi Technologies (DEFT) secured an additional 180‑day Nasdaq compliance period, buying time to resolve listing issues while management explores strategic options.

Securitize (SECZ) and Dubai's Virtual Assets Regulatory Authority signed a memorandum of understanding to advance regulated tokenised markets, an arrangement that could accelerate institutional participation in tokenized asset frameworks.

Operational wins and commercial expansion

Polyrizon (PLRZ) announced a $4.0 million registered direct offering and private placement to fund near‑term growth initiatives, though shareholders should weigh dilution against execution prospects.

Healthcare Triangle (HCTI) said it will distribute a minority interest of Teyame AI Holdings to shareholders ahead of a planned direct listing, a move that can unlock AI asset value and create new comparables for investors.

• The Toro Company (TTC) — record Q3 results.
• Milestone Pharmaceuticals (MIST) — NMPA approval for etripamil in China.
• BUUU Group Limited (BUUU) — acquisition and $60M+ placements to scale AI data‑center delivery.

Traders and investors will parse today’s mix — regulatory approvals, strategic M&A and capital raises, contract extensions, and targeted repurchases — to update valuations and sector weightings. Watch for follow‑on guidance, filing details and commercial rollouts that typically drive the next leg of stock moves.